48-hours Moisturization Potential of Piramal Lacto calamine Vitamin C Gel

A Clinical Study to Evaluate the 48-hours Moisturization Potential of Piramal Lacto calamine Vitamin C Gel on Healthy Human Subjects - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2024/12/078452

Enrollment

Registered

2024-12-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Piramal Lacto Calamine Vitamin C Gel: Dose: Gently massage approx. 1 drop of over one block as assigned (forearm) Route of Administration: Topical Duration: 48 hour Contro

Eligibility

Inclusion criteria

Inclusion criteria: 1.Gender: Male or Female with age 18-50. 2. Subjects willing to give written informed consent 3.Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4.Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events 5. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing mothers 2. Subject with oily skin or with too much Sweating 3. Have open sores or open lesions in the treatment area(s).. 4.Scars, excessive terminal hair or tattoo on the studied area 5.Henna tattoo anywhere on the body (in case of studies involving hair dyes) 6.Dermatological infection or pathology on the level of studied area 7.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 8.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 9.Chronic illness which may influence the outcome of the study 10.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 11.Have a known sensitivity to any of the constituents of the test product 12.Have not skin related issues

Design outcomes

Primary

Measure	Time frame
Change in hydrationTimepoint: T0min, T+30min, T+2hrs, T+8hrs, T+24hrs, T+48hours	—

Secondary

Measure	Time frame
Change in TEWLTimepoint: T0min, T30min, T24hrs, T48hrs	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results